# Kforce Inc: financial statements, quarterly

KFRC · NYSE · CIK 930420 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kfrc.md) · [Financials](/companies/kfrc/financials.md) · [Filings](/companies/kfrc/filings.md) · [Insiders](/companies/kfrc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/kfrc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [373](/filings/0000930420-24-000210.md) | [363 d](/filings/0000930420-26-000007.md) | [352](/filings/0000930420-25-000105.md) | [356](/filings/0000930420-25-000181.md) | [353](/filings/0000930420-25-000197.md) | [344 d](/filings/0000930420-26-000007.md) | [330](/filings/0000930420-26-000041.md) | [334](/filings/0000930420-26-000063.md) | [333](/filings/0000930420-25-000197.md) | [332 d](/filings/0000930420-26-000007.md) | [330](/filings/0000930420-26-000041.md) | [349](/filings/0000930420-26-000063.md) |
| Cost of revenue | $m | [270](/filings/0000930420-24-000210.md) | [264 d](/filings/0000930420-26-000007.md) | [257](/filings/0000930420-25-000105.md) | [257](/filings/0000930420-25-000181.md) | [255](/filings/0000930420-25-000197.md) | [251 d](/filings/0000930420-26-000007.md) | [242](/filings/0000930420-26-000041.md) | [244](/filings/0000930420-26-000063.md) | [240](/filings/0000930420-25-000197.md) | [242 d](/filings/0000930420-26-000007.md) | [240](/filings/0000930420-26-000041.md) | [250](/filings/0000930420-26-000063.md) |
| Gross profit | $m | [103](/filings/0000930420-24-000210.md) | [99.4 d](/filings/0000930420-26-000007.md) | [95.3](/filings/0000930420-25-000105.md) | [99.0](/filings/0000930420-25-000181.md) | [98.6](/filings/0000930420-25-000197.md) | [92.7 d](/filings/0000930420-26-000007.md) | [88.3](/filings/0000930420-26-000041.md) | [90.6](/filings/0000930420-26-000063.md) | [92.3](/filings/0000930420-25-000197.md) | [90.2 d](/filings/0000930420-26-000007.md) | [90.1](/filings/0000930420-26-000041.md) | [99.5](/filings/0000930420-26-000063.md) |
| Selling, general and administrative | $m | [86.2](/filings/0000930420-24-000210.md) | [76.4 d](/filings/0000930420-26-000007.md) | [78.2](/filings/0000930420-25-000105.md) | [77.7](/filings/0000930420-25-000181.md) | [78.3](/filings/0000930420-25-000197.md) | [75.6 d](/filings/0000930420-26-000007.md) | [75.2](/filings/0000930420-26-000041.md) | [74.4](/filings/0000930420-26-000063.md) | [75.9](/filings/0000930420-25-000197.md) | [80.3 d](/filings/0000930420-26-000007.md) | [76.8](/filings/0000930420-26-000041.md) | [79.4](/filings/0000930420-26-000063.md) |
| Operating income | $m | [16.0](/filings/0000930420-24-000210.md) | [21.8 d](/filings/0000930420-26-000007.md) | [15.7](/filings/0000930420-25-000105.md) | [19.7](/filings/0000930420-25-000181.md) | [18.7](/filings/0000930420-25-000197.md) | [15.6 d](/filings/0000930420-26-000007.md) | [11.6](/filings/0000930420-26-000041.md) | [14.9](/filings/0000930420-26-000063.md) | [15.0](/filings/0000930420-25-000197.md) | [8.6 d](/filings/0000930420-26-000007.md) | [12.0](/filings/0000930420-26-000041.md) | [18.8](/filings/0000930420-26-000063.md) |
| Income tax | $m | [5.3](/filings/0000930420-24-000210.md) | [5.7 d](/filings/0000930420-26-000007.md) | [4.1](/filings/0000930420-25-000105.md) | [5.0](/filings/0000930420-25-000181.md) | [4.1](/filings/0000930420-25-000197.md) | [4.0 d](/filings/0000930420-26-000007.md) | [2.9](/filings/0000930420-26-000041.md) | [3.4](/filings/0000930420-26-000063.md) | [3.2](/filings/0000930420-25-000197.md) | [2.6 d](/filings/0000930420-26-000007.md) | [3.4](/filings/0000930420-26-000041.md) | [5.4](/filings/0000930420-26-000063.md) |
| Net income | $m | [10.6](/filings/0000930420-24-000210.md) | [15.7 d](/filings/0000930420-26-000007.md) | [11.0](/filings/0000930420-25-000197.md) | [14.2](/filings/0000930420-25-000197.md) | [14.2](/filings/0000930420-25-000197.md) | [11.1 d](/filings/0000930420-26-000007.md) | [8.1](/filings/0000930420-26-000063.md) | [10.4](/filings/0000930420-26-000063.md) | [11.1](/filings/0000930420-25-000197.md) | [5.2 d](/filings/0000930420-26-000007.md) | [7.9](/filings/0000930420-26-000063.md) | [12.3](/filings/0000930420-26-000063.md) |
| Diluted EPS | $ per share | [0.54](/filings/0000930420-24-000210.md) | not reported | [0.58](/filings/0000930420-25-000105.md) | [0.75](/filings/0000930420-25-000181.md) | [0.75](/filings/0000930420-25-000197.md) | not reported | [0.45](/filings/0000930420-26-000041.md) | [0.59](/filings/0000930420-26-000063.md) | [0.63](/filings/0000930420-25-000197.md) | not reported | [0.46](/filings/0000930420-26-000041.md) | [0.73](/filings/0000930420-26-000063.md) |
| Basic EPS | $ per share | [0.55](/filings/0000930420-24-000210.md) | not reported | [0.59](/filings/0000930420-25-000105.md) | [0.76](/filings/0000930420-25-000181.md) | [0.76](/filings/0000930420-25-000197.md) | not reported | [0.45](/filings/0000930420-26-000041.md) | [0.59](/filings/0000930420-26-000063.md) | [0.63](/filings/0000930420-25-000197.md) | not reported | [0.46](/filings/0000930420-26-000041.md) | [0.74](/filings/0000930420-26-000063.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.1](/filings/0000930420-23-000225.md) | [0.1](/filings/0000930420-25-000022.md) | [0.1](/filings/0000930420-24-000080.md) | [0.1](/filings/0000930420-24-000159.md) | [0.1](/filings/0000930420-24-000210.md) | [0.3](/filings/0000930420-26-000007.md) | [0.4](/filings/0000930420-25-000105.md) | [2.5](/filings/0000930420-25-000181.md) | [1.3](/filings/0000930420-25-000197.md) | [2.1](/filings/0000930420-26-000063.md) | [1.3](/filings/0000930420-26-000041.md) | [0.3](/filings/0000930420-26-000063.md) |
| Current assets | $m | [258](/filings/0000930420-23-000225.md) | [244](/filings/0000930420-25-000022.md) | [246](/filings/0000930420-24-000080.md) | [239](/filings/0000930420-24-000159.md) | [240](/filings/0000930420-24-000210.md) | [225](/filings/0000930420-26-000007.md) | [230](/filings/0000930420-25-000105.md) | [223](/filings/0000930420-25-000181.md) | [218](/filings/0000930420-25-000197.md) | [202](/filings/0000930420-26-000063.md) | [217](/filings/0000930420-26-000041.md) | [231](/filings/0000930420-26-000063.md) |
| Total assets | $m | [370](/filings/0000930420-23-000225.md) | [358](/filings/0000930420-25-000022.md) | [366](/filings/0000930420-24-000080.md) | [363](/filings/0000930420-24-000159.md) | [370](/filings/0000930420-24-000210.md) | [358](/filings/0000930420-26-000007.md) | [368](/filings/0000930420-25-000105.md) | [374](/filings/0000930420-25-000181.md) | [374](/filings/0000930420-25-000197.md) | [366](/filings/0000930420-26-000063.md) | [385](/filings/0000930420-26-000041.md) | [410](/filings/0000930420-26-000063.md) |
| Current liabilities | $m | [119](/filings/0000930420-23-000225.md) | [103](/filings/0000930420-25-000022.md) | [106](/filings/0000930420-24-000080.md) | [103](/filings/0000930420-24-000159.md) | [117](/filings/0000930420-24-000210.md) | [112](/filings/0000930420-26-000007.md) | [111](/filings/0000930420-25-000105.md) | [109](/filings/0000930420-25-000181.md) | [116](/filings/0000930420-25-000197.md) | [114](/filings/0000930420-26-000063.md) | [122](/filings/0000930420-26-000041.md) | [120](/filings/0000930420-26-000063.md) |
| Total liabilities | $m | [191](/filings/0000930420-23-000225.md) | [199](/filings/0000930420-25-000022.md) | [202](/filings/0000930420-24-000080.md) | [196](/filings/0000930420-24-000159.md) | [202](/filings/0000930420-24-000210.md) | [203](/filings/0000930420-26-000007.md) | [230](/filings/0000930420-25-000105.md) | [239](/filings/0000930420-25-000181.md) | [242](/filings/0000930420-25-000197.md) | [241](/filings/0000930420-26-000063.md) | [267](/filings/0000930420-26-000041.md) | [287](/filings/0000930420-26-000063.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [179](/filings/0000930420-24-000210.md) | [159](/filings/0000930420-26-000007.md) | [165](/filings/0000930420-25-000197.md) | [167](/filings/0000930420-25-000197.md) | [167](/filings/0000930420-25-000197.md) | [155](/filings/0000930420-26-000063.md) | [138](/filings/0000930420-26-000063.md) | [134](/filings/0000930420-26-000063.md) | [132](/filings/0000930420-25-000197.md) | [125](/filings/0000930420-26-000063.md) | [117](/filings/0000930420-26-000063.md) | [124](/filings/0000930420-26-000063.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [28.6 d](/filings/0000930420-24-000210.md) | [22.4 d](/filings/0000930420-26-000007.md) | [13.2](/filings/0000930420-25-000105.md) | [20.9 d](/filings/0000930420-25-000181.md) | [31.0 d](/filings/0000930420-25-000197.md) | [21.8 d](/filings/0000930420-26-000007.md) | [0.2](/filings/0000930420-26-000041.md) | [18.4 d](/filings/0000930420-26-000063.md) | [23.3 d](/filings/0000930420-25-000197.md) | [19.7 d](/filings/0000930420-26-000007.md) | [(4.1)](/filings/0000930420-26-000041.md) | [(2.7) d](/filings/0000930420-26-000063.md) |
| Capital expenditure | $m | [1.1 d](/filings/0000930420-24-000210.md) | [1.7 d](/filings/0000930420-26-000007.md) | [1.9](/filings/0000930420-25-000105.md) | [3.1 d](/filings/0000930420-25-000181.md) | [3.5 d](/filings/0000930420-25-000197.md) | [(0.9) d](/filings/0000930420-26-000007.md) | [4.1](/filings/0000930420-26-000041.md) | [4.1 d](/filings/0000930420-26-000063.md) | [3.5 d](/filings/0000930420-25-000197.md) | [3.0 d](/filings/0000930420-26-000007.md) | [3.3](/filings/0000930420-26-000041.md) | [3.8 d](/filings/0000930420-26-000063.md) |
| Dividends paid | $m | [6.9 d](/filings/0000930420-24-000210.md) | [6.7 d](/filings/0000930420-26-000007.md) | [7.1](/filings/0000930420-25-000105.md) | [7.1 d](/filings/0000930420-25-000181.md) | [7.1 d](/filings/0000930420-25-000197.md) | [7.0 d](/filings/0000930420-26-000007.md) | [7.1](/filings/0000930420-26-000041.md) | [6.9 d](/filings/0000930420-26-000063.md) | [6.8 d](/filings/0000930420-25-000197.md) | [6.7 d](/filings/0000930420-26-000007.md) | [6.8](/filings/0000930420-26-000041.md) | [6.7 d](/filings/0000930420-26-000063.md) |
| Share repurchases | $m | [16.9 d](/filings/0000930420-24-000210.md) | [33.6 d](/filings/0000930420-26-000007.md) | [2.8](/filings/0000930420-25-000105.md) | [8.4 d](/filings/0000930420-25-000181.md) | [10.0 d](/filings/0000930420-25-000197.md) | [20.7 d](/filings/0000930420-26-000007.md) | [21.1](/filings/0000930420-26-000041.md) | [11.2 d](/filings/0000930420-26-000063.md) | [9.2 d](/filings/0000930420-25-000197.md) | [9.4 d](/filings/0000930420-26-000007.md) | [11.7](/filings/0000930420-26-000041.md) | [3.4 d](/filings/0000930420-26-000063.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [20.5](/filings/0000930420-23-000225.md) | [19.7](/filings/0000930420-24-000080.md) | [19.6](/filings/0000930420-24-000159.md) | [19.5](/filings/0000930420-24-000210.md) | [18.9](/filings/0000930420-25-000105.md) | [18.9](/filings/0000930420-25-000181.md) | [18.8](/filings/0000930420-25-000197.md) | [18.2](/filings/0000930420-26-000041.md) | [17.8](/filings/0000930420-26-000063.md) | [17.6](/filings/0000930420-25-000197.md) | [17.2](/filings/0000930420-26-000041.md) | [17.0](/filings/0000930420-26-000063.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 17,909,000 at 2026-07-22, from the cover of the [10-Q filed 2026-07-29](/filings/0000930420-26-000063.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.